203 related articles for article (PubMed ID: 27432413)
1. Safety, efficacy and predictors of local recurrence after percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma.
Su MZ; Memon F; Lau HM; Brooks AJ; Patel MI; Woo HH; Bariol SV; Vladica P
Int Urol Nephrol; 2016 Oct; 48(10):1609-16. PubMed ID: 27432413
[TBL] [Abstract][Full Text] [Related]
2. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
3. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors for Long-Term Survival in Patients with Renal-Cell Carcinoma After Radiofrequency Ablation.
Zhang F; Chang X; Liu T; Wang W; Zhao X; Ji C; Yang R; Guo H
J Endourol; 2016 Jan; 30(1):37-42. PubMed ID: 26222920
[TBL] [Abstract][Full Text] [Related]
6. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma.
Iguchi T; Hiraki T; Tomita K; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Kanazawa S
Diagn Interv Imaging; 2016 Nov; 97(11):1159-1164. PubMed ID: 27256108
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
9. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
13. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation for renal tumours: A retrospective study from a tertiary centre.
Al-Zubaidi M; Lotter K; Marshall M; Lozinskiy M
Asian J Urol; 2023 Apr; 10(2):177-181. PubMed ID: 36942114
[TBL] [Abstract][Full Text] [Related]
16. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
17. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
20. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]